Production of specific polyclonal antibodies anti-human factor IX

Production of specific polyclonal antibodies anti-human factor IX

In this work, polyclonal antibodies anti-human Factor IX were produced in New Zealand rabbits by immunization with commercial pure human FIX (hFIX) (Octanyne®, Octapharma, USA). The serum containing immunoglobulins anti-hFIX was useful to detect hFIX antigen in human plasma fractions submitted to an...

Full description

Bibliographic Details
Main Authors:	Daniel Gonçalves Chaves, Cibele Velloso Rodrigues, Wanderley Almeida Ferreira, Pollyana Fantini Miranda Siqueira, Clara Guerra Duarte, Anna Bárbara de Freitas Carneiro-Proietti, Marcelo Matos Santoro
Format:	Article
Language:	English
Published:	Instituto de Tecnologia do Paraná (Tecpar) 2006-07-01
Series:	Brazilian Archives of Biology and Technology
Subjects:	Factor IX hemophilia B HPLC purification antibodies ELISA
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132006000500010

Similar Items

Purificación del factor IX recombinante expresado en leche de cerdas transgénicas Purification of recombinant factor IX expressed in milk of transgenic sows
by: Armando Cádiz Lahens, et al.
Published: (2006-08-01)

The Clinical Genetics of Hemophilia B (Factor IX Deficiency)
by: Miller CH
Published: (2021-11-01)

Prevention and Reversal of Antibody Responses Against Factor IX in Gene Therapy for Hemophilia B
by: Sushrusha eNayak, et al.
Published: (2011-12-01)

Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B
by: Richard Lemons, et al.
Published: (2024-01-01)

Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models
by: David M. Markusic, et al.
Published: (2017-05-01)

Real‐world experience of rIX‐FP prophylaxis at dosing intervals of up to 14 days in a pediatric patient with hemophilia B during the COVID‐19 pandemic
by: Bolívar Luis Díaz‐Jordán, et al.
Published: (2023-12-01)

Evaluation of efficacy of twice-weekly prophylactic treatment with BeneFIX® (recombinant factor IX) followed by once weekly in children with severe hemophilia B: Six-year data from a local registry
by: Rafal Raad Al-Janabi, et al.
Published: (2021-01-01)

Soluble expression of recombinant coagulation factor IX protein using Escherichia coli
by: Byoung-Hee Park, et al.
Published: (2024-07-01)

Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa (rIX‐FP): A case report
by: Francisco José López‐Jaime, et al.
Published: (2023-06-01)

Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy
by: Nils Mülling, et al.
Published: (2021-06-01)

New developments in the management of moderate-to-severe hemophilia B
by: Nazeef M, et al.
Published: (2016-04-01)

Identification and Genetic Analysis of a Factor IX Gene Intron 3 Mutation in a Hemophilia B Pedigree in China
by: Dong Hua Cao, et al.
Published: (2014-08-01)

A Post-Authorization Safety Surveillance Study to Report Clinical Experience with Purified Factor IX Concentrate in Pediatric Patients with Hemophilia B
by: Igrutinović Z, et al.
Published: (2024-03-01)

Importancia del diagnóstico de portadoras en familias con antecedentes de hemofilia
by: Kalia Lavaut Sánchez

“Prevalence of Inhibitors in Hemophilia Patients and its Clinical Implications”: A Study of 276 Patients in Western India
by: Sangita Darshan Shah, et al.
Published: (2019-01-01)

Indouralica IX
by: Bojan Čop
Published: (1989-12-01)

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
by: Jacky K. Yu, et al.
Published: (2019-07-01)

Physical activity and bleeding outcomes among people with severe hemophilia on extended half‐life or conventional recombinant factors
by: Anshu Shrestha, et al.
Published: (2021-01-01)

Preliminary study on non-viral transfection of F9 (factor IX) gene by nucleofection in human adipose-derived mesenchymal stem cells
by: Susana Olmedillas López, et al.
Published: (2016-04-01)

Efficient detection of factor IX mutations by denaturing high-performance liquid chromatography in Taiwanese hemophilia B patients, and the identification of two novel mutations
by: Pei-Chin Lin, et al.
Published: (2014-04-01)

A new technique of quantifying protoporphyrin IX in microbial cells in seawater
by: Lide Gu, et al.
Published: (2022-09-01)

Expression of the human coagulation factor IX in the bone marrow mesenchymal stem cells
by: Azadehsadat Azadbakhsh, et al.
Published: (2014-05-01)

Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples
by: Cecilia Augustsson, et al.
Published: (2020-10-01)

Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)
by: Tine M.H.J. Goedhart, et al.
Published: (2022-01-01)

Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh
by: Mohammed Nadimul Islam, et al.
Published: (2022-07-01)

Genetic variation of rs438601 marker in the Iranian Population: An informative marker for molecular diagnosis of hemophilia B
by: P Dorri, et al.
Published: (2014-12-01)

Perioperative Management of Patients with Hemophilia during Spinal Surgery
by: Kazuyoshi Kobayashi, et al.
Published: (2018-06-01)

Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies
by: Pratima Chowdary, et al.
Published: (2022-07-01)

Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model
by: Lorenzo Pradelli, et al.
Published: (2018-01-01)

Perspectives of Title IX Pioneers
by: Lisa M. Rubin, et al.
Published: (2015-12-01)

Synthesis of new derivatives of protoporphyrin IX
by: V. Yu. Pavlov, et al.
Published: (2010-10-01)

An update on anticancer drug development and delivery targeting carbonic anhydrase IX
by: Justina Kazokaitė, et al.
Published: (2017-11-01)

LIBRO RESÚMENES IX ENCUENTRO DE INVESTIGACIÓN ODONTOLOGÍA UC
by: ARS MEDICA
Published: (2021-08-01)

Integration the relativistic wave equations in Bianchi IX cosmology model
by: Alexander Igorevich Breev, et al.
Published: (2016-06-01)

Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease
by: Rita C. Santoro, et al.
Published: (2021-09-01)

Molecular characterization of hemophilia B patients in Colombia
by: Yolima A. Parrado Jara, et al.
Published: (2020-05-01)

Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B
by: Linna Lu, et al.
Published: (2023-05-01)

The odds and implications of coinheritance of hemophilia A and B
by: Corinne Karch, et al.
Published: (2020-07-01)

A Case of Heel Reconstruction with a Reverse Sural Artery Flap in a Hemophilia B Patient
by: Byung Kwon Lee, et al.
Published: (2012-03-01)

A Case of Heel Reconstruction with a Reverse Sural Artery Flap in a Hemophilia B Patient
by: Byung Kwon Lee, et al.
Published: (2012-03-01)